Patent AT-E401400-T1: [Translated] ANTIANGIOGENIC PEPTIDES FOR THE TREATMENT OR PREVENTION OF ENDOMETRIOSIS
HealthData.Gov
Updated Oct 29, 2026
About this dataset
Provided herein are peptides from the N-terminal of endostatin proteins, including the first histidine of the protein, nucleic acids encoding the peptides, pharmaceutical compositions comprising the nucleic acids and proteins and methods for using the pharmaceutical compositions to treat or prevent endometriosis in a subject.
Data and resources (1)
- HTML
Official Data Source
Access the complete Patent AT-E401400-T1: [Translated] ANTIANGIOGENIC PEPTIDES FOR THE TREATMENT OR PREVENTION OF ENDOMETRIOSIS on the official website.
Modified May 29, 2026